Plasma and cellular ivacaftor concentrations in patients with cystic fibrosis
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.26093
Abstract: Access to cystic fibrosis transmembrane conductance regulator (CFTR) modulators has been gradually increasing for people with cystic fibrosis, the first of which was ivacaftor, a CFTR potentiator that is part of all clinically available modulator… read more here.
Keywords: ivacaftor concentrations; plasma cellular; concentrations patients; cellular ivacaftor ... See more keywords